Pharvaris PHVS
NASDAQ PHVS
$31.31 -0.41 (-1.29%)
As of: Oct 1, 2026 · 1:15 PM EDT

Pharvaris (PHVS) Accumulated Expenses (2019 - 2026)

Updated

Pharvaris (PHVS) posted Accumulated Expenses of $28.35 trillion for Q2 2026, compared with $21.96 million a year earlier and up 27.1% from the prior quarter.

Analysis

Pharvaris (PHVS) Accumulated Expenses (2019 - 2026) Analysis & Trends

At the end of FY2025, Pharvaris' Accumulated Expenses came in at $26.38 trillion, up 38.6% from FY2024.

  • Annual Accumulated Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 38.9% (FY2020 to FY2025).
  • In prior years, Pharvaris' Accumulated Expenses was $19.04 trillion in FY2024 (+59.0%), $11.97 trillion in FY2023 (+4.3%), $11.48 trillion in FY2022 (+127.2%) and $5.05 trillion in FY2021 (-0.9%).
  • The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2019.
  • On a year-over-year basis, Accumulated Expenses increased in three of the last six quarters, with an average decline of 31.9%.
  • The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q3 2022, with growth of 137.5%; the weakest was Q2 2025, with a decline of 100.0%.
  • According to Business Quant data, Accumulated Expenses for the three prior quarters was $22.3 trillion (Q1 2026), $27.18 trillion (Q4 2025) and $26.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Pharvaris 2.07 Bn -289,124.33 Bn 85,072.10
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 28,349.37 Bn
Mar 31, 2026 22,298.15 Bn
Dec 31, 2025 27,178.64 Bn
Sep 30, 2025 26.51 Mn
Jun 30, 2025 21.96 Mn
Mar 31, 2025 18.05 Mn
Dec 31, 2024 18,794.89 Bn
Sep 30, 2024 13,261.71 Bn
Jun 30, 2024 17,076.87 Bn
Mar 31, 2024 13,198.78 Bn
Dec 31, 2023 11,907.98 Bn
Sep 30, 2023 12,502.74 Bn
Jun 30, 2023 11,151.58 Bn
Mar 31, 2023 10,608.83 Bn
Dec 31, 2022 11,111.26 Bn
Sep 30, 2022 10.21 Mn
Jun 30, 2022 9.58 Mn
Mar 31, 2022 7.33 Mn
Dec 31, 2021 4,884.85 Bn
Sep 30, 2021 4.30 Mn
API Access

Pharvaris Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PHVS&period=max&api_key=YOUR_API_KEY